1Y Close · As of Aug 26, 2026
SAMJIN PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: SAMJIN PHARMACEUTICAL CO.,LTD
In fiscal year 2022, SAMJIN PHARMACEUTICAL (005500) reported revenue of 274.0 billion KRW, up 9.6% from 250.1 billion KRW a year earlier.
Operating profit was 23.2 billion KRW and net income was 21.9 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 247.1 billion KRW, with a P/B of 0.85.
These figures can be verified in the DART filing (receipt no. 20260316001338).
Recent Filings
Officer/Major Shareholder Ownership Report
Officer/Major Shareholder Ownership Report
Officer/Major Shareholder Ownership Report
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-25 | Officer/Major Shareholder Ownership Report |
| 2026-08-25 | Officer/Major Shareholder Ownership Report |
| 2026-08-25 | Officer/Major Shareholder Ownership Report |
| 2026-08-25 | Large Shareholding Report (General) |
| 2026-08-25 | Large Shareholding Report (General) |